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Heart failure is a growing epidemic. Over the last decade,
the annual number of hospitalizations has increased from
800,000 to over a million for heart failure as a primary, and
from 2.4 to 3.6 million for heart failure as a primary or
secondary diagnosis. Approximately 50% of heart failure
patients are rehospitalized within 6 months of discharge.
With aging of the population, heart failure rates and the
associatedhospitalizationswillcontinuetorise.Thecomplex
array of physiologic, psychological, social, and health care
deliveryissuesmakesitachallengingchronicdiseasetoman-
age. Understanding the epidemiology and pathophysiology
ofthesyndrome,identifyingthepredictorsandtheirstrength
of association with outcomes, and using the available
diagnostic modalities cost-eﬀectively are essential in order
to devise eﬀective prevention interventions and implement
novel therapeutic approaches to curb this epidemic. In this
special issue on heart failure, we have invited a few papers
that address such issues.
The ﬁrst two papers provide insight into the epidemiol-
ogy of two speciﬁc populations: women and children. The
former is a systematic review of qualitative studies that
examined the inﬂuence of sex and gender on heart failure
self-care. It identiﬁes that women with chronic heart failure
represent a highly vulnerable population that needs more
support for psychosocial well-being and self-care. The latter
is a prospective study aiming to evaluate the long-term
eﬀects of therapy for childhood lymphoma on cardiac
function using clinical parameters, electrocardiography, and
echocardiography. The authors report that most parameters
of cardiac function remain normal in survivors of childhood
lymphoma after a mean follow up of almost 11 years. This is
likely due to relatively low doses of anthracyclines in modern
protocol modalities. However, they comment that frequent
abnormalities in mitral valve ﬂow and QTc prolongation
necessitate long-term cardiac follow up in this population.
Shedding light into pathophysiology pathways the fol-
lowing 3 papers deal with 3 distinct and interesting ﬁelds:
hyperthyroidism, right ventricular function, and inﬂamma-
tory cardiomyopathy. The ﬁrst is an original research paper
that evaluates the eﬀect of acute experimental hyperthy-
roidism on basal and volume-induced atrial natriuretic pep-
tide secretion in healthy subjects. The second describes the
development of right ventricular dysfunction and failure in
patients with chronic pressure overload. The third review
gives an overview about how inﬂammation triggers the
functionality of mesenchymal stem cells, how it induces car-
diac homing and, ﬁnally, discusses the potential of intra-
venous application of such cells.
Moving to noninvasive diagnostic modalities, we provide
a thorough review of multimodality imaging of chronic
ischemia using echocardiographic strain, magnetic reso-
nance, and histology ﬁndings in a chronic ischemia model
in preclinical study. This case illustrates the features of mul-
timodality imaging in chronic obstructive coronary disease
and gives us great insight in understanding the mechanism
of ischemic cardiomyopathy. The next paper underscores
the role of acoustic cardiography in the detection of left
ventricular systolic dysfunction in patients with chronic
atrial ﬁbrillation. In the same section, the reader may ﬁnd
an interesting case report of isolated left ventricular non-
compaction with a strange ECG-tracing strongly suggestive
of Brugada syndrome.2 Cardiology Research and Practice
The following section of this focused issue contains 3
papers devoted to novel therapeutic approaches in heart
failure. The ﬁrst is an original prospective study that
evaluates the eﬃcacy and safety of prolonged levosimendan
infusion, an inotropic drug with unique pharmacological
advantages,inpatientsadmittedwithacuteheartfailure.The
second is a review paper that provides an evidence-based
analysis of how heart failure patients—with and without
systolic dysfunction—beneﬁt from exercise training. The last
paper evaluates the eﬀect of exercise training on interleukin-
6, tumour necrosis factor alpha, and functional capacity in
heart failure patients.
Next session moves the reader to the ﬁelds of person-
alized medicine and myocardial regeneration therapy. First,
we discuss the role of individual genetic background in the
progression of left ventricular dysfunction and remodelling
in heart failure patients under optimal medical therapy, in
a prospective study that performed a genotype analysis for
ACE I/D, β-1 adrenergic receptor (AR) Arg389Gly, β-2AR
Arg16Gly, and β-2AR Gln27Glu polymorphisms. Then, we
presentanoveltechniqueforthedevelopmentofbioartiﬁcial
myocardium using stem cells and nanobiotechnology tem-
plates.
T h eﬁ n a lp a r to ft h i ss p e c i a li s s u ei sd e v o t e dt oc o n t e m -
porary device therapies and contains 5 papers. An original
study suggests that cardiac resynchronization therapy (CRT)
improves hemodynamic condition and exercise capacity and
reduces the ventilator response during eﬀort. The second
paper presents a prospective study that aims to predict the
response to CRT implantation by comparing pre-CRT left
ventricular dyssynchrony by tissue Doppler imaging and
regional volumetric analysis by 3-dimensional transthoracic
echocardiography. The following paper describes the use of
epicardial electrogram as a simple guide to select optimal site
ofleftventricularpacing inCRT.Theforthpaperisafocused
review on transthoracic echocardiographic assessment of
patients with continuous axial left ventricular assist devices.
We close this special issue with a thorough review on the
role of device diagnostic algorithms in the assessment and
management of patients with systolic heart failure.
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